التفاصيل البيبلوغرافية
| العنوان: |
CCR5-Δ32 polymorphism: a possible protective factor for post-stroke depressive symptoms. |
| المؤلفون: |
Tene, Oren, Hallevi, Hen, Molad, Jeremy, Usher, Saly, Seyman, Estelle, Bornstein, Natan M., Shenhar-Tsarfaty, Shani, Ben Assayag, Einor |
| المصدر: |
Journal of Psychiatry & Neuroscience; Jul2021, Vol. 46 Issue 4, pE431-E440, 10p |
| مصطلحات موضوعية: |
PREVENTION of mental depression, GENETIC mutation, STROKE, TRANSIENT ischemic attack, TIME, GERIATRIC Depression Scale, ALLELES, SEX distribution, HEALTH care teams, MENTAL depression, CARRIER state (Communicable diseases), DISEASE complications |
| مستخلص: |
Background: A naturally occurring loss-of-function mutation in the gene for C-C chemokine receptor type 5 (CCR5 -Δ32) has recently been reported as a protective factor in post-stroke motor and cognitive recovery. We sought to examine whether this mutation also prevented the development of depressive symptoms up to 2 years after a stroke. Methods: Participants were survivors of a first-ever mild to moderate ischemic stroke or transient ischemic attack from the TABASCO prospective study who underwent a 3 T MRI at baseline and were examined by a multiprofessional team 6, 12 and 24 months after the event, including an evaluation of depressive symptoms using the Geriatric Depression Scale. Results: CCR5 -Δ32 status and a baseline depression evaluation were available for 435 patients. Compared with noncarriers, CCR5 -Δ32 carriers (16.1%) had fewer depressive symptoms at admission (p = 0.035) and at 6 months (p < 0.001), 12 months (p < 0.001) and 24 months (p = 0.006) after the index event. This association remained significant at 6 and 12 months after adjustment for age, sex, education, antidepressant use, ethnicity and the presence of cortical infarcts. These findings were more robust in women. Compared to baseline, depressive symptoms in CCR5 -Δ32 noncarriers tended to remain stable or grow worse over time, but in CCR5 -Δ32 carriers, symptoms tended to improve. Limitations: A limitation of this study was the exclusion of patients who had a severe stroke or who had pre-stroke depression. Conclusion: Carriers of the CCR5 -Δ32 allele had a lower tendency to develop depressive symptoms post-stroke, and this phenomenon was more prominent in women. These findings could have clinical implications; they suggest a mechanism-based treatment target for post-stroke depression. Drugs mimicking this loss-of-function mutation exist and could serve as a novel antidepressant therapy. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Psychiatry & Neuroscience is the property of CMA Impact Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder